Aduro Biotech (ADRO) Posts Q1 Loss of $39.97/Share

Aduro Biotech (NASDAQ: ADRO) reported Q1 EPS of ($39.97), $39.89 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $9.24 million.

The company posted a loss of $26.34 per share in the same period last year.

For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.

You May Also Be Interested In

• First Industrial Realty (FR) Tops Q1 EPS by 21c
• Equifax (EFX) Tops Q1 EPS by 6c, Misses on Revenue; Offers Guidance
• CSX reiterates FY outlook as Q1 results top estimates